Skip to main content
    T

    Tscan Therapeutics Inc (TCRX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.15
    +0.01 (+4.07%)

    Market Cap: $10.89M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Tscan Therapeutics Inc (TCRX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Tscan Therapeutics (TCRX) has a latest price of $0.15 on Nov 17, 2026, 89.7% below its 52-week high of $1.47. Its price fell 86.3% over the past 12 months. The month-end price fell 98.0% over the 5 years through Oct 2026, a compound annual decline of 54.3%.

    Price Chart

    From Jul 2021 to Oct 2026, its highest month-end close was $9.70 in Jul 2021 and its lowest $0.17 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart TCRX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for TCRX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 79.9%, and over 6 months it fell 84.3%. The month-end price fell 95.5% over the 3 years through Oct 2026, a compound annual decline of 64.3%.

    PeriodChange
    1 month-28.2%
    3 months-79.9%
    6 months-84.3%
    12 months-86.3%
    12 months, with dividends-86.3%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-95.5%-64.3%
    5 years-98.0%-54.3%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2023, when the price rose 276.1%, and its weakest was 2025, when it fell 67.1%.

    YearCloseChange
    2026 through Oct 2026$0.17-82.6%
    2025$1.00-67.1%
    2024$3.04-47.9%
    2023$5.83+276.1%
    2022$1.55-65.6%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 39.7% below its 50-day average of $0.25 and 81.0% below its 200-day average of $0.80.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.15
    52-week high$1.47-89.7%
    52-week low$0.14+4.1%
    50-day average$0.25-39.7%
    200-day average$0.80-81.0%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 98.5%.

    MeasureValue
    1-year beta1.83
    Largest fall, 1 year-89.9%
    Largest fall, 3 years-98.5%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About TCRX

    What is TCRX's 1-year price change?

    Tscan Therapeutics's price fell 86.3% over the past 12 months. With dividends included, the 12-month total return was -86.3%.

    What is TCRX's 5-year price change?

    Tscan Therapeutics's month-end price fell 98.0% over the 5 years through Oct 2026, a compound annual decline of 54.3%. These figures leave out dividends.

    What is TCRX's 52-week high and low?

    Tscan Therapeutics's 52-week high is $1.47 and its 52-week low is $0.14. Its latest price of $0.15 on Nov 17, 2026 is 89.7% below the high.

    What is TCRX's beta?

    Tscan Therapeutics's 1-year beta against the S&P 500 is 1.83, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 89.9%.

    Is the TCRX chart free?

    Yes. Advanced Charting for TCRX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.